Výsledky vyhľadávania - "Peptide Fragments/blood"
-
1
Autori: a ďalší
Zdroj: Maurer, M S, Berk, J L, Damy, T, Sheikh, F H, González-Costello, J, Morbach, C, Delgado, D, Bondue, A, Azevedo, O, Poulsen, S H, Jankowska, E A, Yang, L, Bender, S, Eraly, S A, Jay, P Y, Vest, J & Fontana, M 2025, 'Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B', Journal of the American College of Cardiology, vol. 86, no. 6, pp. 459-475. https://doi.org/10.1016/j.jacc.2025.04.055
Predmety: Male, Cardiomyopathies/blood, N-terminal prohormone of B-type natriuretic peptide, amyloidosis, cardiac biomarkers, transthyretin amyloidosis cardiomyopathy, troponin I, Middle Aged, Prognosis, Amyloid Neuropathies, Familial/blood, Troponin I/blood, Double-Blind Method, RNAi Therapeutics/methods, Humans, Prealbumin, Female, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Biomarkers/blood, Aged, Troponin T/blood
-
2
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Osteoporos Int
Bhattoa, H P, Vasikaran, S, Trifonidi, I, Kapoula, G, Lombardi, G, Jørgensen, N R, Pikner, R, Miura, M, Chapurlat, R, Hiligsmann, M, Haarhaus, M, Evenepoel, P, Jørgensen, H M S, Herrmann, M, Kaufman, J M, Clark, P, Tuzun, Ş, Al-Daghri, N, Silverman, S, Alokail, M S, Ormarsdóttir, S, Yerro, M C P, Matijevic, R, Laslop, A, Rosa, M M C D S, Zakraoui, L, Burlet, N, McCloskey, E, Harvey, N C, Radermecker, R P, Fusaro, M, Torre, C, Kanis, J A, Rizzoli, R, Reginster, J Y, Makris, K & Cavalier, E 2025, 'Update on the role of bone turnover markers in the diagnosis and management of osteoporosis : a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)', Osteoporosis International, vol. 36, no. 4, 513925, pp. 579-608. https://doi.org/10.1007/s00198-025-07422-3
Bhattoa, H P, Vasikaran, S, Trifonidi, I, Kapoula, G, Lombardi, G, Jørgensen, N R, Pikner, R, Miura, M, Chapurlat, R, Hiligsmann, M, Haarhaus, M, Evenepoel, P, Jørgensen, H S, Herrmann, M, Kaufman, J-M, Clark, P, Tuzun, Ş, Al-Daghri, N, Silverman, S, Alokail, M S, Ormarsdóttir, S, Yerro, M C P, Matijevic, R, Laslop, A, da Silva Rosa, M M C, Zakraoui, L, Burlet, N, McCloskey, E, Harvey, N C, Radermecker, R P, Fusaro, M, Torre, C, Kanis, J A, Rizzoli, R, Reginster, J-Y, Makris, K & Cavalier, E 2025, ' Update on the role of bone turnover markers in the diagnosis and management of osteoporosis : a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) ', Osteoporosis International, vol. 36, no. 4, pp. 579-608 . https://doi.org/10.1007/s00198-025-07422-3
Bhattoa, H P, Vasikaran, S, Trifonidi, I, Kapoula, G, Lombardi, G, Jørgensen, N R, Pikner, R, Miura, M, Chapurlat, R, Hiligsmann, M, Haarhaus, M, Evenepoel, P, Jørgensen, H S, Herrmann, M, Kaufman, J M, Clark, P, Tuzun, Ş, Al-Daghri, N, Silverman, S, Alokail, M S, Ormarsdóttir, S, Yerro, M C P, Matijevic, R, Laslop, A, da Silva Rosa, M M C, Zakraoui, L, Burlet, N, McCloskey, E, Harvey, N C, Radermecker, R P, Fusaro, M, Torre, C, Kanis, J A, Rizzoli, R, Reginster, J Y, Makris, K & Cavalier, E 2025, 'Update on the role of bone turnover markers in the diagnosis and management of osteoporosis : a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)', Osteoporosis International, vol. 36, no. 4, pp. 579-608. https://doi.org/10.1007/s00198-025-07422-3Predmety: Procollagen/blood, CHRONIC KIDNEY-DISEASE, Peptides/blood, Endocrinology, Diabetes and Metabolism, 4202 Epidemiology, Osteoporotic Fractures/etiology, N-TERMINAL PROPEPTIDE, beta-CTX-I, 0903 Biomedical Engineering, Osteoporosis/therapy, Human health sciences, Bone Density Conservation Agents, Osteoporosis/diagnosis, procollagen Type I N-terminal peptide, ß-CTX-I, Bone Remodeling/physiology, POSTMENOPAUSAL WOMEN, Position Paper, Bone Remodeling, Osteoporosis/physiopathology, Bone turnover markers, Life Sciences & Biomedicine, Procollagen, Osteoporosis/drug therapy, I PROCOLLAGEN PINP, Bone Density Conservation Agents/therapeutic use, Consensus, Collagen Type I/blood, β-CTX-I, Public health, health care sciences & services, Osteoporosis/blood, Bone status indices, Sciences de la santé humaine, Risk Assessment, Santé publique, services médicaux & soins de santé, AGE-RELATED-CHANGES, Collagen Type I, 1117 Public Health and Health Services, Endocrinology & Metabolism, SERUM OSTEOPROTEGERIN LEVELS, Humans, collagen type I trimeric cross-linked peptide, Risk Assessment/methods, BIOCHEMICAL MARKERS, Science & Technology, Osteoporotic Fractures/prevention & control, 3202 Clinical sciences, 1103 Clinical Sciences, TRACP5b, Peptide Fragments, PINP, Osteoporosis, REFERENCE INTERVALS, MINERAL DENSITY, Peptide Fragments/blood, BALP, Peptides, Biomarkers/blood, Biomarkers, Osteoporotic Fractures, GROWTH-FACTOR 23
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40152990
https://cris.maastrichtuniversity.nl/en/publications/acf11ebf-2ab3-4a07-98f2-2e687a89dfbb
https://doi.org/10.1007/s00198-025-07422-3
https://hdl.handle.net/20.500.12831/27042
https://doi.org/10.1007/s00198-025-07422-3
https://hdl.handle.net/2268/334682
https://doi.org/10.1007/s00198-025-07422-3
https://pergamos.lib.uoa.gr/uoa/dl/object/3498391
https://curis.ku.dk/ws/files/452215655/s00198-025-07422-3.pdf
http://www.scopus.com/inward/record.url?scp=105001872684&partnerID=8YFLogxK
https://doi.org/10.1007/s00198-025-07422-3
https://pure.au.dk/portal/en/publications/c06bf694-f1fd-400b-9b38-53c4223ed5dd -
3
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Revista espanola de cardiologia, vol. 78, no. 2, pp. 107-116
Tran, Fabian; Ruperti-Repilado, Francisco Javier; Haaf, Philip; Ayala, Pedro Lopez; Greutmann, Matthias; Schwerzmann, Markus; Bouchardy, Judith; Gabriel, Harald; Stambach, Dominik; Schwitter, Juerg; Wustmann, Kerstin; Freese, Michael; Mueller, Christian; Tobler, Daniel (2024). NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification? (In Press). Revista española de cardiología-English Edition Elsevier Doyma 10.1016/j.rec.2024.05.006 <http://dx.doi.org/10.1016/j.rec.2024.05.006>
Tran, Fabian; Ruperti-Repilado, Francisco Javier; Haaf, Philip; Ayala, Pedro Lopez; Greutmann, Matthias; Schwerzmann, Markus; Bouchardy, Judith; Gabriel, Harald; Stambach, Dominik; Schwitter, Juerg; Wustmann, Kerstin; Freese, Michael; Mueller, Christian; Tobler, Daniel (2025). NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification? Revista española de cardiología-English Edition, 78(2), pp. 107-116. Elsevier Doyma 10.1016/j.rec.2024.05.006 <http://dx.doi.org/10.1016/j.rec.2024.05.006>Predmety: 03 medical and health sciences, 0302 clinical medicine, Humans, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Female, Male, Middle Aged, Prognosis, Adult, Risk Assessment/methods, Heart Ventricles/physiopathology, Heart Ventricles/diagnostic imaging, Biomarkers/blood, Ventricular Function, Right/physiology, Stroke Volume/physiology, Ventricular Dysfunction, Right/blood, Ventricular Dysfunction, Right/physiopathology, Follow-Up Studies, Echocardiography, Survival Rate/trends, Biomarcadores, Biomarkers, Cardiopatías congénitas del adulto, Congenital heart disease, Heart Failure, Insuficiencia cardiaca, Transposición de las grandes arterias, Transposition of the great arteries, 10209 Clinic for Cardiology, 610 Medicine & health, 2705 Cardiology and Cardiovascular Medicine, 3. Good health
Popis súboru: application/pdf; ZORA_270755.pdf - application/pdf
-
4
Autori: a ďalší
Zdroj: J Cachexia Sarcopenia Muscle
Journal of Cachexia, Sarcopenia and Muscle, Vol 16, Iss 3, Pp n/a-n/a (2025)
Soendenbroe, C, Heisterberg, M F, Andersen, J L, Kjaer, M & Mackey, A L 2025, ' Serum C-Terminal Agrin Fragment With Acute and Long-Term Exercise and Angiotensin II Type I Receptor Blockade ', Journal of Cachexia, Sarcopenia and Muscle, vol. 16, no. 3, e13832 . https://doi.org/10.1002/jcsm.13832Predmety: Male, Angiotensin II Type 1 Receptor Blockers/therapeutic use, angiotensin II type I receptor, aging, QM1-695, Resistance Training, Diseases of the musculoskeletal system, Middle Aged, Receptor, Angiotensin, Type 1/metabolism, Agrin/blood, RC925-935, Exercise/physiology, Human anatomy, Humans, biomarker, neuroprotection, Original Article, Peptide Fragments/blood, hypertrophy, neuromuscular system, Biomarkers/blood, Aged
Popis súboru: application/pdf
-
5
Autori: a ďalší
Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 24, Iss 1, Pp 1-12 (2025)Predmety: Coronary Artery Disease/diagnostic imaging blood drug therapy, Male, Time Factors, Diabetic Cardiomyopathies, Ventricular Remodeling/drug effects, Heart failure, Coronary Artery Disease, Spironolactone, Coronary artery disease, Left/drug effects, Ventricular Function, Left, Mineralocorticoid Receptor Antagonists/therapeutic use, Predictive Value of Tests, Risk Factors, 80 and over, Diabetes Mellitus, Ventricular Function, Diseases of the circulatory (Cardiovascular) system, Humans, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, Aged, 80 and over, Collagen markers, Ventricular Remodeling, Research, Diabetes, Middle Aged, Fibrosis, Spironolactone/therapeutic use, Diabetes Mellitus/blood diagnosis epidemiology drug therapy, Treatment Outcome, Echocardiography, RC666-701, Diabetic Cardiomyopathies/diagnostic imaging blood etiology physiopathology, Heart Failure/diagnostic imaging drug therapy physiopathology blood diagnosis, Female, Peptide Fragments/blood, Biomarkers/blood, Biomarkers
-
6
Autori: a ďalší
Zdroj: Clin Res Cardiol
Predmety: Male, Aged, 80 and over, Original Paper, Cardiac Catheterization, Time Factors, COVID-19, Middle Aged, Peptide Fragments, Time-to-Treatment, Hospitalization, 03 medical and health sciences, 0302 clinical medicine, Natriuretic Peptide, Brain, Humans, Female, Female [MeSH], Aged, 80 and over [MeSH], Heart failure, Aged [MeSH], Humans [MeSH], Natriuretic Peptide, Brain/blood [MeSH], Cardiac Catheterization/methods [MeSH], Emergency hospitalizations, Retrospective Studies [MeSH], Middle Aged [MeSH], Time-to-Treatment [MeSH], Hospitalization/statistics, Time Factors [MeSH], Epidemiology, Male [MeSH], COVID-19 pandemic, Peptide Fragments/blood [MeSH], COVID-19/epidemiology [MeSH], Deferral, Retrospective Studies, Aged
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38446147
https://repository.publisso.de/resource/frl:6497023 -
7
Autori: a ďalší
Zdroj: Pediatr Res
Neumann, Roland P; Gerull, Roland; Hasler, Pascal W; Wellmann, Sven; Schulzke, Sven M (2024). Vasoactive peptides as biomarkers for the prediction of retinopathy of prematurity. Pediatric research, 95(7), pp. 1868-1874. Nature Publishing Group 10.1038/s41390-024-03091-w <http://dx.doi.org/10.1038/s41390-024-03091-w>Predmety: Male, Clinical Research Article, Endothelin-1, Infant, Newborn, 610 Medicine & health, Gestational Age, Peptide Fragments, 3. Good health, Logistic Models, Humans, Retinopathy of Prematurity, Female, Prospective Studies, Protein Precursors, Infant, Newborn [MeSH], Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Prospective Studies [MeSH], Retinopathy of Prematurity/blood [MeSH], Retinopathy of Prematurity/diagnosis [MeSH], Protein Precursors/blood [MeSH], Logistic Models [MeSH], Infant, Premature/blood [MeSH], Endothelin-1/blood [MeSH], Male [MeSH], clinical-research-article, Peptide Fragments/blood [MeSH], Atrial Natriuretic Factor/blood [MeSH], Gestational Age [MeSH], Biomarkers, Atrial Natriuretic Factor, Infant, Premature
Popis súboru: application/pdf
-
8
Autori: a ďalší
Zdroj: Osteoporosis International, 36 (4), 579 - 608 (2025-04)
Predmety: BALP, Bone status indices, Bone turnover markers, PINP, TRACP5b, β-CTX-I, Biomarkers, Peptide Fragments, Procollagen, procollagen Type I N-terminal peptide, Collagen Type I, Bone Density Conservation Agents, Peptides, collagen type I trimeric cross-linked peptide, Humans, Biomarkers/blood, Osteoporotic Fractures/prevention & control, Osteoporotic Fractures/etiology, Peptide Fragments/blood, Procollagen/blood, Risk Assessment/methods, Collagen Type I/blood, Bone Density Conservation Agents/therapeutic use, Peptides/blood, Consensus, Bone Remodeling/physiology, Osteoporosis/diagnosis, Osteoporosis/physiopathology, Osteoporosis/drug therapy, Osteoporosis/blood, Osteoporosis/therapy, Bone Remodeling, Osteoporosis, Osteoporotic Fractures, Risk Assessment, Endocrinology, Diabetes and Metabolism, Human health sciences, Public health, health care sciences & services, Sciences de la santé humaine, Santé publique, services médicaux & soins de santé
Relation: https://link.springer.com/content/pdf/10.1007/s00198-025-07422-3.pdf; urn:issn:0937-941X; urn:issn:1433-2965
Prístupová URL adresa: https://orbi.uliege.be/handle/2268/334682
-
9
Autori: a ďalší
Zdroj: Clin Res Cardiol
Predmety: Male, Original Paper, Apolipoprotein A-I, Myocardial Infarction, Middle Aged, Female [MeSH], Follow-Up Studies [MeSH], Apolipoprotein A-I/blood [MeSH], Aged [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Chest pain, Natriuretic Peptide, Brain/blood [MeSH], Hepatitis A Virus Cellular Receptor 1/blood [MeSH], Predictive Value of Tests [MeSH], Middle Aged [MeSH], Risk prediction, Biomarker, Acute coronary syndrome, Male [MeSH], Peptide Fragments/blood [MeSH], Prognosis [MeSH], Myocardial Infarction/diagnosis [MeSH], Machine Learning [MeSH], Myocardial Infarction/blood [MeSH], Risk Assessment/methods [MeSH], NT-proBNP, Prognosis, Risk Assessment, Peptide Fragments, 3. Good health, Machine Learning, Predictive Value of Tests, Natriuretic Peptide, Brain, Humans, Female, Hepatitis A Virus Cellular Receptor 1, Biomarkers, Aged, Follow-Up Studies
Popis súboru: pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38078957
https://repository.publisso.de/resource/frl:6497791 -
10
Autori:
Zdroj: Liječnički vjesnik ; ISSN 1849-2177 (Online) ; ISSN 0024-3477 (Print) ; ISSN-L 0024-3477 ; CODEN LIVJA5 ; Volume 147 ; Issue 1-2
Predmety: BIOMARKERI – u krvi, SEPSA – dijagnoza, JEDINICE INTENZIVNOG LIJEČENJA, BROJ LEUKOCITA – analiza, C-REAKTIVNI PROTEIN – u krvi, INTERLEUKIN-6 – u krvi, PROTEIN PANKREASNOG KAMENCA – u krvi, PROKALCITONIN – u krvi, PEPTIDNI FRAGMENTI – u krvi, LIPOPOLISAHARIDNI RECEPTORI – u krvi, MONOCITI, BIOMARKERS – blood, SEPSIS – diagnosis, INTENSIVE CARE UNITS, LEUKOCYTE COUNT – analysis, C-REACTIVE PROTEIN – blood, INTERLEUKIN-6 – blood, LITHOSTATHINE – blood, PROCALCITONIN – blood, PEPTIDE FRAGMENTS –blood, LIPOPOLYSACCHARIDE RECEPTORS – blood, MONOCYTES
Relation: https://hrcak.srce.hr/328796
-
11
Autori: a ďalší
Zdroj: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-12 (2024)
Alzheimer's research & therapy 16(1), 279 (2024). doi:10.1186/s13195-024-01647-wPredmety: blood [Frontotemporal Dementia], Male, 0301 basic medicine, blood [Neurofilament Proteins], Mass Spectrometry, diagnosis [Frontotemporal Dementia], 0302 clinical medicine, Neurofilament Proteins, blood [Amyloid beta-Peptides], blood [Glial Fibrillary Acidic Protein], Alzheimer Disease/blood [MeSH], Frontotemporal lobar degeneration, Aged, 80 and over [MeSH], Aged [MeSH], Amyloid-beta, Blood biomarker, Mass spectrometry, Frontotemporal Dementia/diagnosis [MeSH], Diagnosis, Differential [MeSH], Differential diagnosis, Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Neurofilament Proteins/blood [MeSH], Peptide Fragments/blood [MeSH], tau Proteins/blood [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Dementia, Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Glial Fibrillary Acidic Protein/blood [MeSH], Frontotemporal Dementia/blood [MeSH], Middle Aged [MeSH], Research, Mass Spectrometry/methods [MeSH], Immunoprecipitation/methods [MeSH], Amyloid beta-Peptides/blood [MeSH], Aged, 80 and over, ddc:610, blood [Biomarkers], diagnosis [Alzheimer Disease], Middle Aged, amyloid beta-protein (1-42), blood [Peptide Fragments], Frontotemporal Dementia, Female, RC321-571, blood [tau Proteins], Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, Diagnosis, Differential, 03 medical and health sciences, blood [Alzheimer Disease], Alzheimer Disease, Glial Fibrillary Acidic Protein, Humans, Immunoprecipitation, neurofilament protein L, RC346-429, Aged, Amyloid beta-Peptides, methods [Mass Spectrometry], GFAP protein, human, amyloid beta-protein (1-40), Peptide Fragments, cerebrospinal fluid [tau Proteins], Neurology. Diseases of the nervous system, Biomarkers, methods [Immunoprecipitation]
Popis súboru: application/pdf
-
12
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-13 (2024)Predmety: Male, 0301 basic medicine, tau Proteins/blood, SLEEP QUALITY, Intradaily variability, 0302 clinical medicine, Neurofilament Proteins, Neurofilament light chain, Glial Fibrillary Acidic Protein/blood, 24-h rest-activity patterns, Aged, 80 and over, Sex Characteristics, Alzheimer Disease/blood, Amyloid beta-Peptides/blood, IMPAIRMENT, Middle Aged, amyloid beta-protein (1-42), Life sciences, Circadian Rhythm, ACTIVITY RHYTHM, Neurology, DISTURBANCES, Sciences du vivant, Circadian Rhythm/physiology, Female, FRAGMENTATION, Amyloid-beta, RC321-571, Adult, Cognitive Neuroscience, Rest, BETA, MAPT protein, human, Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, Glial fibrillary acidic protein, 03 medical and health sciences, AGE, Alzheimer Disease, Sex differences, Glial Fibrillary Acidic Protein, Neurofilament Proteins/blood, Interdaily stability, Humans, CYCLE, neurofilament protein L, Plasma biomarkers, RC346-429, Aged, Alzheimer Disease/physiopathology, Amyloid beta-Peptides, GFAP protein, human, Research, Rest/physiology, Actigraphy, Peptide Fragments, Neurology (clinical), Neurology. Diseases of the nervous system, Tau, TAU, Peptide Fragments/blood, Biomarkers/blood, Biomarkers
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39736697
https://doaj.org/article/66c49208f22046d3b01423bc74f08891
https://cris.maastrichtuniversity.nl/en/publications/65872054-915a-4d15-a4ea-4dc2dd67797f
https://doi.org/10.1186/s13195-024-01653-y
https://hdl.handle.net/2268/326175
https://doi.org/10.1186/s13195-024-01653-y -
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Lung. 203
Predmety: Male, Adult, Sarcoidosis, Cardiomyopathies/diagnosis, Sex Factors, Troponin T, Predictive Value of Tests, Natriuretic Peptide, Brain, Tachycardia, Ventricular/diagnosis, Journal Article, Humans, Troponin T/blood, Retrospective Studies, Aged, Middle Aged, Sarcoidosis/diagnosis, Peptide Fragments, Early Diagnosis, Electrocardiography, Ambulatory, Tachycardia, Ventricular, Female, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Cardiomyopathies, Biomarkers/blood, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39621157
https://dspace.library.uu.nl/handle/1874/459553 -
14
Autori: a ďalší
Zdroj: Eur J Pediatr
Predmety: Male, Endothelin-1, Research, Hypertension, Pulmonary, Infant, Newborn, Hemodynamics, Gestational Age, Risk Assessment, Peptide Fragments, 03 medical and health sciences, 0302 clinical medicine, Echocardiography, Predictive Value of Tests, Infant, Newborn [MeSH], Infant, Premature [MeSH], Pulmonary hypertension, Natriuretic Peptide, Brain/blood [MeSH], Biomarker, Endothelin-1/blood [MeSH], Mortality, Male [MeSH], Peptide Fragments/blood [MeSH], Echocardiography [MeSH], Hypertension, Pulmonary/blood [MeSH], Hemodynamics/physiology [MeSH], Risk Assessment/methods [MeSH], Female [MeSH], Preterm infants, Biomarkers/blood [MeSH], Humans [MeSH], Prospective Studies [MeSH], Bronchopulmonary Dysplasia/diagnosis [MeSH], Longitudinal Studies [MeSH], Predictive Value of Tests [MeSH], Hypertension, Pulmonary/diagnosis [MeSH], Bronchopulmonary dysplasia, Bronchopulmonary Dysplasia/blood [MeSH], Hypertension, Pulmonary/physiopathology [MeSH], Infant, Very Low Birth Weight/blood [MeSH], Gestational Age [MeSH], Hypertension, Pulmonary/etiology [MeSH], Natriuretic Peptide, Brain, Humans, Infant, Very Low Birth Weight, Female, Prospective Studies, Longitudinal Studies, Biomarkers, Infant, Premature, Bronchopulmonary Dysplasia
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39546006
https://repository.publisso.de/resource/frl:6497512 -
15
Autori: a ďalší
Zdroj: Trials
Trials, Vol 25, Iss 1, Pp 1-12 (2024)
Kunkel, J B, Holle, S L D, Hassager, C, Pecini, R, Wiberg, S, Palm, P, Holmvang, L, Bang, L E, Kjærgaard, J, Thomsen, J H, Engstrøm, T, Møller, J E, Lønborg, J T, Frydland, M & Søholm, H 2024, ' Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T) : study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial ', Trials, vol. 25, no. 1, 739 . https://doi.org/10.1186/s13063-024-08573-0Predmety: Male, Medicine (General), Time Factors, Humanized/therapeutic use, Myocardial Infarction, Anti-Inflammatory Agents, Anti-Inflammatory Agents/therapeutic use, Left/drug effects, Percutaneous coronary intervention, Study Protocol, Risk Factors, Receptors, Monoclonal, Natriuretic Peptide, Brain, Ventricular Function, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Shock, IL-6RA, Tocilizumab, Middle Aged, Neurohormonal activation, ORBI risk score, Treatment Outcome, Female, Adult, Shock, Cardiogenic, Acute myocardial infarction, Antibodies, Monoclonal, Humanized, Risk Assessment, Antibodies, R5-920, Percutaneous Coronary Intervention, Double-Blind Method, Natriuretic Peptide, Cardiogenic/etiology, Humans, Cardiogenic shock, Cardiac magnetic resonance imaging, Aged, Inflammation, Receptors, Interleukin-6, Peptide Fragments, Interleukin-6/antagonists & inhibitors, ProBNP, Brain/blood, Myocardial Infarction/blood, Peptide Fragments/blood, Biomarkers/blood, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39501388
https://doaj.org/article/cc0311fa571748c7ae1243f0f04615cf
https://curis.ku.dk/ws/files/412387809/s13063_024_08573_0.pdf
https://portal.findresearcher.sdu.dk/da/publications/26bb7167-6b1c-4983-9f26-2bc65bb288c0
https://doi.org/10.1186/s13063-024-08573-0 -
16
Autori: a ďalší
Zdroj: Trials
Trials, Vol 25, Iss 1, Pp 1-12 (2024)
Holle, S L D, Kunkel, J B, Hassager, C, Pecini, R, Wiberg, S, Palm, P, Holmvang, L, Bang, L E, Kjærgaard, J, Thomsen, J H, Engstrøm, T, Møller, J E, Lønborg, J T, Søholm, H & Frydland, M 2024, ' Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial) : study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial ', Trials, vol. 25, no. 1, 731 . https://doi.org/10.1186/s13063-024-08567-yPredmety: Infusions, Medicine (General), Cardiotonic Agents, Time Factors, Transthoracic echocardiography, Shock, Cardiogenic, Myocardial Infarction, Acute myocardial infarction, Risk Assessment, Percutaneous coronary intervention, Study Protocol, R5-920, Percutaneous Coronary Intervention, Double-Blind Method, Natriuretic Peptide, Risk Factors, Cardiogenic/etiology, Dobutamine, Natriuretic Peptide, Brain, Humans, Hemodynamic, Infusions, Intravenous, Cardiogenic shock, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Cardiotonic Agents/administration & dosage, Dobutamine/administration & dosage, Hemodynamics, Shock, Peptide Fragments, Inotropy, Neurohormonal activation, Hemodynamics/drug effects, ORBI risk score, Treatment Outcome, Brain/blood, Peptide Fragments/blood, Intravenous, Biomarkers/blood, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39478521
https://doaj.org/article/a5d155d3071647e4bf0a269a4072873f
https://curis.ku.dk/ws/files/411693416/s13063_024_08567_y.pdf
https://portal.findresearcher.sdu.dk/da/publications/c3615b61-7329-4827-8066-bb65d616ddd2
https://doi.org/10.1186/s13063-024-08567-y -
17
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: J Am Heart Assoc
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Journal of the American Heart Association : Cardiovascular and cerebrovascular diseasePredmety: Male, Heart Failure/physiopathology, Cardiac & Cardiovascular Systems, stress echocardiography, DISEASE, Ventricular Function, Left, 0302 clinical medicine, Diastole, pulmonary hypertension, Natriuretic Peptide, Brain, Prospective Studies, Cardiac Output, 1102 Cardiorespiratory Medicine and Haematology, Original Research, Exercise Test/methods, clinical relevance, Middle Aged, oxygen consumption, 3. Good health, DEFICIENCY, Female, ECHOCARDIOGRAPHY, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, Echocardiography, Stress, Cardiac Output/physiology, Hypertension, Pulmonary, PRESSURE, DIAGNOSIS, CAPACITY, 03 medical and health sciences, diastole, Oxygen Consumption, Predictive Value of Tests, Hypertension, Pulmonary/physiopathology, Diseases of the circulatory (Cardiovascular) system, Humans, Aged, Heart Failure, exercise testing, Clinical Relevance, Science & Technology, diastolic heart failure, Stroke Volume, dyspnea, HFpEF, Peptide Fragments, Stroke Volume/physiology, RC666-701, Cardiovascular System & Cardiology, Exercise Test, Human medicine, Natriuretic Peptide, Brain/blood, Ventricular Function, Left/physiology, Peptide Fragments/blood
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39028104
https://doaj.org/article/1d13c3c29d1449e1a7e8cb12dec19fef
https://hdl.handle.net/10067/2076320151162165141
https://repository.uantwerpen.be/docstore/d:irua:24936
https://biblio.vub.ac.be/vubir/clinical-significance-of-exercise-pulmonary-hypertension-with-a-negative-diastolic-stress-test-for-suspected-heart-failure-with-preserved-ejection-fraction(42b219ea-a02b-4c8d-8ef1-5bccd4b97fa1).html -
18
Autori: a ďalší
Zdroj: BMC Nephrol
BMC Nephrology, Vol 25, Iss 1, Pp 1-16 (2024)
Davies, E M, Buckley, B J R, Austin, P, Lip, G Y H, Oni, L, McDowell, G & Rao, A 2024, 'Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database', BMC Nephrology, vol. 25, no. 1, 233. https://doi.org/10.1186/s12882-024-03667-yPredmety: Male, Adult, Databases, Factual, Cardiovascular Diseases/blood, MACE, Cardiovascular, Cohort Studies, 03 medical and health sciences, Glomerulonephritis, 0302 clinical medicine, Predictive Value of Tests, Natriuretic Peptide, Brain, Humans, Glomerulonephritis/blood, Mortality, Retrospective Studies, Aged, Research, Incidence, Troponin I, Biomarker, Middle Aged, Prognosis, Diseases of the genitourinary system. Urology, Peptide Fragments, 3. Good health, Troponin I/blood, Cardiovascular Diseases, Female, RC870-923, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Biomarkers/blood, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39039475
https://doaj.org/article/f3c3dcddc4b24ad09589815d8cf81b5e
https://vbn.aau.dk/ws/files/738886430/Davies_et_al._2024_._Routine_cardiac_biomarkers_for_the_prediction_of_incident_major_adverse_cardiac_events_in_patients_with_glomerulonephritis_-_a_real-world_analysis_using_a_global_federated_database.pdf
https://doi.org/10.1186/s12882-024-03667-y
http://www.scopus.com/inward/record.url?scp=85199184215&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/696a37e4-b863-4a98-b3ac-8694b5a8db0b -
19
Autori: a ďalší
Zdroj: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-10 (2024)Predmety: Male, 0301 basic medicine, Fluid biomarkers, Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, p-tau, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Neurofilament Proteins, Glial Fibrillary Acidic Protein, Humans, RC346-429, Aβ, Aged, Aged, 80 and over, Amyloid beta-Peptides, Research, Alzheimer Disease/blood [MeSH], Neurofilament Proteins/cerebrospinal fluid [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Amyloid beta-Peptides/cerebrospinal fluid [MeSH], Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Neurofilament Proteins/blood [MeSH], Glial Fibrillary Acidic Protein/cerebrospinal fluid [MeSH], Peptide Fragments/blood [MeSH], Circadian Rhythm/physiology [MeSH], Diurnal variability, tau Proteins/blood [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Sampling time, Glial Fibrillary Acidic Protein/blood [MeSH], Middle Aged [MeSH], Biomarkers/cerebrospinal fluid [MeSH], Peptide Fragments/cerebrospinal fluid [MeSH], Amyloid beta-Peptides/blood [MeSH], Alzheimer Disease/cerebrospinal fluid [MeSH], Middle Aged, 16. Peace & justice, Peptide Fragments, Circadian Rhythm, 3. Good health, Female, Neurology. Diseases of the nervous system, Biomarkers, RC321-571
-
20
Autori: a ďalší
Zdroj: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-11 (2024)Predmety: 576.5, Male, 0301 basic medicine, 616.8, Hippocampus / diagnostic imaging, Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, Neuroimaging, Hippocampus, Hippocampus / pathology, 618.97, 03 medical and health sciences, Neurofilament Proteins / blood, 0302 clinical medicine, Neurofilament Proteins, Glial Fibrillary Acidic Protein, Biomarkers / blood, Humans, Cognitive Dysfunction / diagnostic imaging, Cognitive Dysfunction, RC346-429, Cognitive Dysfunction / blood, Aged, Amyloid beta-Peptides, 616.0757, Research, Amyloid beta-Peptides / blood, Glial Fibrillary Acidic Protein / blood, Middle Aged, Peptide Fragments / blood, Peptide Fragments, 3. Good health, Tau Proteins / blood, Positron-Emission Tomography, Female, Neurology. Diseases of the nervous system, Neuroimaging / methods, Biomarkers, RC321-571
Popis súboru: application/pdf
Nájsť tento článok vo Web of Science
Full Text Finder